The 20 Best Brown Syndrome Doctors in Maryland, US

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as an Elite provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Elite provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Movement Disorders.

David L. Guyton, M.D., is the Zanvyl Krieger Professor of Ophthalmology. He is internationally known for his contributions, inventions, and teaching in the fields of ophthalmic optics, clinical refraction, potential acuity testing, and ocular motility. His clinical practice in strabismus is heavily surgical, both pediatric and adult, with emphasis on re-operations and cyclovertical surgery, using adjustable sutures. With adults comprising more than 80 percent of his strabismus surgical cases, Dr. Guyton has contributed significantly to our knowledge of strabismus complications from local anesthetics, the “inverted Brown pattern,” the “dragged-fovea diplopia syndrome,” theories of how and why strabismus develops in the first place, and how and why it can change over time. Dr. Guyton is currently developing automated instruments for the vision screening of infants and children. Dr. Guyton is rated as a Distinguished provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, and Esotropia.

With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.

David Newman-Toker, M.D., Ph.D., is an internationally recognized leader in neuro-otology, acute stroke diagnosis, and diagnostic errors research. He completed his undergraduate studies at Yale University, his medical degree at University of Pennsylvania, his residency training and neuro-ophthalmology fellowship at Harvard University, his neuro-otology fellowship at Johns Hopkins University School of Medicine, and his doctoral degree in clinical research methods at the Johns Hopkins Bloomberg School of Public Health. He has served as a full-time faculty member at the Johns Hopkins University School of Medicine since 2002. He is the David Robinson Professor of Vestibular Neurology and also holds appointments in Otolaryngology, Ophthalmology, Emergency Medicine, Acute Care Nursing, Health Sciences Informatics, Epidemiology, and Health Policy & Management at Johns Hopkins. Dr. Newman-Toker is a bedside-to-populations translational researcher, with a focus on eliminating diagnostic errors and achieving diagnostic excellence. He is a leader in the national and international movements to eliminate patient harms from diagnostic error. Dr. Newman-Toker’s clinical focus is on diagnosis of acute disorders affecting the brainstem and cranial nerves, particularly stroke. He is recognized for his research in novel eye-movement-based bedside methods for diagnosing stroke in patients with acute dizziness and vertigo in the emergency department and, in 2024, won the international Bárány Society’s Hallpike-Nylén Prize for clinical research achievement. Dr. Newman-Toker serves as director of the Division of Neuro-Visual & Vestibular Disorders in the Department of Neurology. He also directs the Armstrong Institute Center for Diagnostic Excellence, whose mission is to catalyze efforts to improve diagnostic performance, develop the science of diagnostic safety, and enhance diagnostic research. He has been the principal investigator on numerous National Institutes of Health, Agency for Healthcare Research and Quality (AHRQ), and foundation grants. He has published over 165 journal articles and given more than 300 invited lectures. He has served as an expert consultant on diagnostic safety and quality to AHRQ, the National Quality Forum, and the National Academy of Medicine. He has testified before Congress on the use of artificial intelligence for medical diagnosis. He was president of the Society to Improve Diagnosis in Medicine from 2018-2020. Dr. Newman is rated as a Distinguished provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Stroke, and Brown Syndrome.

Courtney L. Kraus, M.D., is Knights Templar Eye Foundation Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins Medicine. Dr. Kraus specializes in pediatric ophthalmology and adult strabismus, including amblyopia (lazy eye), with a particular interest in pediatric cataract and corneal diseases. She has enjoyed participating in surgical mission trips to underserved areas in the developing world. Dr. Kraus received her medical degree from Washington University in St. Louis, Missouri, where she also completed her residency in ophthalmology after an internship in internal medicine at St. John’s Mercy Medical Center in Creve Coeur, Missouri. She then completed a fellowship in pediatric ophthalmology and adult strabismus at the Storm Eye Institute at The Medical University of South Carolina. Dr. Kraus is rated as an Advanced provider by MediFind in the treatment of Brown Syndrome. Her top areas of expertise are Strabismus, Idiopathic Short Stature (ISS), Brown Syndrome, Vitrectomy, and Cataract Removal.

Dr. Couser obtained his bachelor’s degree from the University of Virginia and his Medical Doctorate from the Virginia Commonwealth University School of Medicine (VCU SOM). Dr. Couser’s ophthalmology residency was completed at Howard University where he served as co-chief resident in the last year of his residency. He received fellowship training in pediatric ophthalmology and adult strabismus at Emory University. Dr. Couser received a master’s degree in biotechnology from the Johns Hopkins University and completed a residency in clinical genetics at the University of North Carolina at Chapel Hill. He is one of only a few individuals currently board-certified by both the American Board of Ophthalmology and the American Board of Medical Genetics and Genomics. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/couser-cv Research Summary My primary research focus involves the identification and management of genetic eye diseases including rare inherited disorders affecting the eyes. Research and scholarly activities have been an integral component of my career path. I have been the principal investigator on 10 clinical trial/IRB studies and a co-investigator on others, participated with several committees or advisory panels related to research activities. I have been credited with over 120 book chapter, journal article and abstract publications. In addition, I served as the primary author/sole editor for a textbook titled Ophthalmic Genetic Diseases: A Quick Reference Guide to the Eye and External Ocular Adnexa Abnormalities, 1st Edition, published by Elsevier in 2018, which is one of only a few textbooks published in this subject area. I also served as a grant review panelist for the National Eye Institute Career Development Awards. Selected Publications *Couser NL, Masood MM, Strande NT, Foreman AKM, Crooks K, Weck KE, Lu M, Wilhelmsen KC, Roche M, Evans JP, Berg JS, Powell CM. 2015. The phenotype of multiple congenital anomalies- hypotonia-seizures syndrome 1: Report and review. Am J Med Genet Part A 9999A:1–6 *Couser NL, Lambert SR. Botulinum toxin: A treatment of consecutive esotropia in children. Strabismus 2012; 20(4):158-161 Couser NL, Lenhart PD, Hutchinson AK. Augmented Hummelsheim procedure to treat complete abducens nerve palsy. J AAPOS 2012;16(4):331-5 *Natario L. Couser, Maheer M. Masood, Arthur S. Aylsworth, and Roger E. Stevenson. Ocular manifestations in the X-linked intellectual disability syndromes. Ophthalmic Genet. 2017, Jan 23:1-12 *Couser NL, Brooks BP, Drack AV, Shankar SP. The evolving role of genetics in ophthalmology. Ophthalmic Genet. 2021 Jan 12:1-4. doi: 10.1080/13816810.2020.1868011. Dr. Couser is rated as an Advanced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Epicanthal Folds, Strabismus, Brown Syndrome, and Hypotonia.

Dr. Richard Leigh is an Assistant Professor of Neurology who is devoted to the diagnosis, treatment and prevention of cerebrovascular disease. He is an attending on the inpatient stroke service and an integral part of the Brain Attack Team. He also provides consultations and follow-up care for cerebrovascular disease in the outpatient setting. Dr. Richard Leigh was originally trained as a biomedical engineer at the Johns Hopkins University and subsequently went on to work at the National Institutes of Health where he developed brain imaging software. He then embarked on obtaining his medical degree from Case Western Reserve School of Medicine in his home town of Cleveland, Ohio. He completed his medical internship and neurology residency at New York Presbyterian Hospital Weill Cornell Medical Center where he received the Distinguished House Staff Award and was selected to be Chief Resident of Neurology. Returning to Johns Hopkins, he then completed a stroke fellowship and subsequently joined the faculty of the cerebrovascular division. Dr. Leigh currently sees patients at the Stroke Prevention Clinic, located in the Johns Hopkins Outpatient Center in Baltimore on Wednesday afternoons, and cares for patients in The Johns Hopkins Hospitals Brain Rescue Unit. Dr. Leigh is rated as an Advanced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Stroke, Brown Syndrome, CACH Syndrome, Emphysema, and Thrombectomy.

Liana Rosenthal, M.D. is an Assistant Professor in the Department of Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Rosenthal completed medical school at Johns Hopkins with an internship at Johns Hopkins Bayview Medical Center. She completed her neurology residency and movement disorder fellowship at The Johns Hopkins Hospital. Dr. Rosenthal is rated as an Advanced provider by MediFind in the treatment of Brown Syndrome. Her top areas of expertise are Movement Disorders, Parkinson's Disease, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.

Bo Wang, M.D., Ph.D., is an assistant professor of ophthalmology with the Wilmer Eye Institute, Johns Hopkins Medicine at Wilmer's East Baltimore and Green Spring Station locations. He specializes in pediatric ophthalmology, with particular interest in pediatric glaucoma and pediatric cataract, strabismus and retinopathy of prematurity. He received his bachelor's and doctorate degrees in bioengineering from the University of Pittsburgh, and completed his medical training at the University of Pittsburgh School of Medicine. He completed his ophthalmology residency at the Wilmer Eye Institute and fellowship in pediatric ophthalmology and adult strabismus at the Duke Eye Center. With a research interest in the application of noninvasive imaging techniques to better understand and manage ocular diseases that affect children, Dr. Wang is using optical coherence tomography, a noninvasive optical imaging technique, to investigate changes in the outflow pathway that lead to pediatric glaucoma. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Strabismus, and Brown Syndrome.

David Zee is a Neurologist in Baltimore, Maryland. Dr. Zee is rated as a Distinguished provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Vertigo, Brown Syndrome, Cerebelloparenchymal Disorder 3, and Benign Paroxysmal Positional Vertigo.

Thomas Bosley is a Neurologist in Baltimore, Maryland. Dr. Bosley is rated as a Distinguished provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Duane-Radial Ray Syndrome, Sulfite Oxidase Deficiency, Isolated Duane Retraction Syndrome, and Brown Syndrome.

Stephen Reich is a Neurologist in Baltimore, Maryland. Dr. Reich is rated as a Distinguished provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Movement Disorders, Parkinson's Disease, Supranuclear Ophthalmoplegia, Deep Brain Stimulation, and Gastrostomy.

Arens Taga is a neurologist specializing in neuromuscular diseases, with a particular focus on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. His clinical work aims to improve the quality of care for patients with ALS through biomarker-based, precision medicine approaches that refine disease stratification and facilitate more targeted and efficient enrollment in clinical trials. As a clinician-scientist, Dr. Taga uses patient-derived induced pluripotent stem cells to model ALS, uncover novel disease mechanisms and identify therapeutic targets that are translatable to clinical trials. In recognition of his work in ALS, Dr. Taga was awarded the 2025 Richard Olney Clinician Scientist Development Award, which honors early-career physician-scientists dedicated to advancing ALS research. Dr. Taga earned his medical degree from the School of Medicine and Surgery at the University of Parma, Italy, where he also completed his neurology residency. He subsequently trained at The Johns Hopkins University, completing a postdoctoral research fellowship in the neuromuscular division, an internal medicine internship, a neurology residency and a neuromuscular clinical fellowship. Dr. Taga is rated as an Experienced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Cluster Headache.

Dr. Saber Tehrani is an Assistant Professor of Neurology at Johns Hopkins University School of Medicine. Dr. Saber Tehrani has unique subspecialty training in vascular neurology, neuro-ophthalmology, and vestibular neurology. He is available for consultation for patients with strokes affecting vision or balance. Research Summary Dr. Saber Tehrani’s research efforts are focused on posterior circulation stroke diagnosis and outcomes, and how such strokes can affect vision and balance. He is using novel ways to objectively measure abnormal eye movements indicative of stroke. Dr. Tehrani is rated as an Experienced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Vertigo, Stroke, Pica, Gastrostomy, and Stent Placement.

Edward Kuwera, M.D. is an ophthalmologist specializing in pediatric conditions and adult strabismus at the Wilmer Eye Institute’s locations in Bel Air and Baltimore, Maryland. His primary focus is on the diagnosis and treatment of complex forms of strabismus (a misalignment of the eyes, usually with double vision, or diplopia), including reoperations, torsional misalignments, and strabismus from thyroid eye disease. Dr. Kuwera is one of very few surgeons in the world who does adjustable surgery for both adults and children, done on the same day. He also has a special interest in children with nystagmus, amblyopia, and cortical visual impairment. Dr. Kuwera graduated Summa Cum Laude from Ross University, where he was a recipient of the Distinguished Scholar Award for academic excellence. Since medical school, Dr. Kuwera has been an advocate of medical and patient education - recognized as Intern Of The Year while training, as well as receiving numerous medical, clinical, and surgical teaching awards throughout his career. He is passionate about involving patients and families in the management of their health concerns and was awarded the Johns Hopkins Hospital Service Star for these interactions. He is actively involved with several projects, among them: VR/AR devices to diagnose and treat visual disorders, optical enhancements to retinoscopy, Lancaster red-green testing, and methods for enhancing trainee and patient learning. As Wilmer's Co-Division Education Champion in ophthalmic optics, Division Education Champion in pediatrics, and Division Fellowship Program Director, Dr. Kuwera provides instruction on clinical skills, surgical techniques, and review of the basic sciences to fellows, residents, and medical students. Visit the site for pediatric eye care instructional videos. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/kuwera-jhu-cv.pdf Recent News Articles and Media Coverage The importance of back-to-school eye exams, DC News Now (September 2024) Passing the Scalpel in Strabismus, Wilmer Insider (June 2021). Dr. Kuwera is rated as an Experienced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Strabismus, Oculomotor Apraxia Cogan Type, Esotropia, and Brown Syndrome.

Jefferson Doyle, M.D., Ph.D., M.H.S. specializes in pediatric ophthalmology and genetic eye diseases and is the recipient of the 2023 Andreas C. Dracopoulos & Daniel Finkelstein, M.D. Rising Professorship in Ophthalmology. His main focus is pediatric and juvenile forms of cataracts, glaucoma, anterior segment dysgenesis, and ectopia lentis. His genetics interests include Marfan syndrome and related connective tissue disorders, complex inherited forms of strabismus in both children and adults (e.g. CFEOM, Duane syndrome), and pediatric retinal dystrophies. Dr. Doyle has published extensively on a number of genetic disorders over the past decade, holds several patents for novel therapeutic approaches to treat them, and has given many national and international talks about them. Dr. Doyle's main research focus is understanding the genetic causes and molecular mechanisms driving genetic diseases, and utilizing that knowledge to develop new therapeutic strategies for them. Over the past decade, he has played a significant role in advancing our understanding of Marfan syndrome and related connective tissue disorders. His work and that of collaborators has led to the discovery of the genetic causes of Shprintzen-Goldberg syndrome and Loeys-Dietz like syndrome. His work has also led to a much better understanding of the molecular mechanisms driving Marfan syndrome, and he holds two patents for novel therapeutic strategies to treat it. Part of his current work focuses on the identification of genes that protect people from developing a number of genetic disorders, and leveraging that knowledge to develop new therapies for those diseases. He also has an interest in pediatric myopia, and has ongoing pre-clinical studies seeking to understand the mechanisms that may drive it and the development of novel therapeutic strategies to treat it. Recent News Articles and Media Coverage A Center for Genetic Eye Disease, Wilmer Insider (Oct. 2021). Dr. Doyle is rated as an Experienced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Duane-Radial Ray Syndrome, Ehlers-Danlos Syndrome (EDS), Vascular Ehlers-Danlos Syndrome (VEDS), and Strabismus.

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Experienced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS).

Andrew R. Carey, MD is a the Neil R. Miller Rising Professor of Ophthalmology in the division of Neuro-Ophthalmology at the Wilmer Eye Institute. He specializes in neuro-ophthalmic disorders such as optic neuritis, uveitis related papillitis, ischemic & hereditary optic neuropathies as well as diseases of the retina, including age-related macular degeneration, diabetic retinopathy, toxic retinopathies and inherited disorders of the retina such as retinitis pigmentosa. Dr. Carey’s clinical and research interests include comparative effectiveness and cost-benefit of intravitreal medications, long-term outcome of treatments for choroidal neovascularization, novel treatments for papillitis, and the use of novel imaging modalities to better diagnose and understand optic nerve and retinal diseases. Dr. Carey received his bachelor's from Davidson College in mathematics in 2006. In 2010, he received his medical degree from the University of South Florida. He completed his ophthalmology residency as Chief Resident in 2014 at the University of South Florida. He then went on to complete his fellowship in neuro-ophthalmology at Bascom Palmer Eye Institute in 2015 and his fellowship in medical retina at the University of Iowa in 2016. Videos Dr. Andrew R. CareyNeuro-Ophthalmology. Dr. Carey is rated as an Experienced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Optic Nerve Atrophy, and Optic Neuritis.

Dr. David Hale is a fellowship-trained neurologist specializing in neuro-visual and vestibular disorders. He diagnoses and treats patients with symptoms including dizziness, vertigo, oscillopsia, double vision and imbalance. Dr. Hale’s patient evaluations include vestibular testing. Dr. Hale earned his medical degree at Pennsylvania State University and completed a neurology residency at the Johns Hopkins University School of Medicine. He remained at Johns Hopkins for fellowship training in vestibular and ocular-motor oto-neurology. Dr. Hale is interested in resident and fellow medical education, specifically the development of ways to make knowledge of subspecialist neurologists more accessible to those in training. He serves as the co-director of the Vestibular and Ocular-Motor Oto-Neurology Clinical Fellowship at Johns Hopkins. Dr. Hale is rated as an Experienced provider by MediFind in the treatment of Brown Syndrome. His top areas of expertise are Vertigo, Miller-Fisher Syndrome, Guillain-Barre Syndrome, and Chronic Polyradiculoneuritis.